Seeing The Importance Of Prevention

In medicine, we often focus on treatment — what to do after disease has already developed. But the most powerful interventions happen long before symptoms appear. Prevention is not just better than cure; in many cases, it's the only truly effective strategy. And genomics is making prevention more precise, more personalized, and more actionable than ever before.

The Three Levels of Prevention

Primary Prevention

Preventing disease before it occurs. This includes lifestyle modifications (diet, exercise, not smoking), vaccinations, and — increasingly — genetic risk-guided interventions. If you know you carry a BRCA1 mutation, you can implement enhanced breast cancer screening and consider risk-reducing surgery before cancer develops. If you know you have elevated genetic cardiovascular risk, you can be more aggressive about lipid management and lifestyle optimization from an early age.

Secondary Prevention

Early detection of disease before symptoms appear, enabling treatment when it's most effective. Cancer screening programs (mammography, colonoscopy, PSA testing, cervical smears) are classic examples. Genetic risk stratification allows screening to be targeted to those at highest risk — maximizing benefit and minimizing unnecessary testing in low-risk individuals.

Tertiary Prevention

Managing existing disease to prevent complications and improve quality of life. Pharmacogenomics plays a key role here — ensuring that medications used to manage chronic conditions are optimally selected and dosed based on the patient's genetic profile.

Why Prevention Is Undervalued

Prevention suffers from a fundamental psychological challenge: the benefits are invisible. When prevention works, nothing happens — no heart attack, no cancer diagnosis, no stroke. It's hard to celebrate the disease you didn't get. Treatment, by contrast, is visible and dramatic. This psychological asymmetry, combined with healthcare systems that are structured around treating disease rather than preventing it, means prevention is chronically underinvested.

Genomics and the Future of Prevention

Genomic medicine is transforming prevention by enabling truly personalized risk assessment. Rather than applying population-average risk statistics to individuals, genetic testing identifies who is at elevated risk for which specific conditions — allowing preventive interventions to be targeted where they will have the greatest impact.

Polygenic risk scores — which aggregate the effects of thousands of common genetic variants — are increasingly being used to identify individuals at high genetic risk for cardiovascular disease, type 2 diabetes, breast cancer, and other common conditions. These scores can identify high-risk individuals who would benefit from earlier and more intensive preventive interventions.

Prevention in the Indian Context

India faces a dual burden of disease — infectious diseases that remain prevalent, and a rapidly rising tide of non-communicable diseases (NCDs) driven by lifestyle transition. NCDs now account for approximately 60% of all deaths in India. The good news: most NCDs are largely preventable through lifestyle modification and early intervention. The challenge: prevention requires sustained behavior change and proactive health engagement that our healthcare system is not yet well-structured to support.

FAQs

How can I start being more proactive about my health?

Start with understanding your risk — family history, lifestyle factors, and genetic testing. Then work with your doctor to implement appropriate screening and preventive interventions based on your personal risk profile. Small, sustainable lifestyle changes compound over time into significant health benefits.

Is genetic testing for prevention worth it?

For most people, yes. Understanding your genetic predispositions allows you to prioritize the preventive interventions most relevant to your specific biology — rather than following generic guidelines that may not apply to you.